Venturini et al. showed that vitexin at concentrations of 0.2, 1, and 5 mg/kg inhibits inflammation in a murine model of OVA-induced allergic asthma via reducing IgE in the serum and inflammatory cells and IL-5, IL-4, and IL-13 in BALF, comparable to dexamethasone (0.5 mg/kg) [143]. This evidence concerns the gene IL13 and allergic asthma.